| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/22/2001 | EP1124956A2 Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect |
| 08/22/2001 | EP1124953A2 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
| 08/22/2001 | EP1124950A2 p53 ANTISENSE AGENT AND METHOD |
| 08/22/2001 | EP1124855A2 Compositions and methods for treating polycystic kidney disease |
| 08/22/2001 | EP1124854A2 Antibodies binding to the aav capsid, antibodies modifying cytotropism, method for targeted gene transfer |
| 08/22/2001 | EP1124850A1 12 human secreted proteins |
| 08/22/2001 | EP1124849A2 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124846A2 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 08/22/2001 | EP1124840A1 Ovary-specific genes and proteins |
| 08/22/2001 | EP1124583A1 Adeno-associated vectors for expression of factor viii by target cells |
| 08/22/2001 | EP1124577A1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS |
| 08/22/2001 | EP1124572A2 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 08/22/2001 | EP1105518A4 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS |
| 08/22/2001 | EP0809516B1 Medicinal combination useful for in vivo exogenic transfection and expression |
| 08/22/2001 | EP0764204B1 HUMAN OXALYL-CoA DECARBOXYLASE |
| 08/22/2001 | CN1309710A Genomic sequences upstream of coding region of IFN-alpha 2 gene for protein production and delivery |
| 08/22/2001 | CN1309709A Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 08/22/2001 | CN1309707A BASB029 polynucleotide(s) and polypeptides from i(neisseria meningitidis) |
| 08/22/2001 | CN1309663A Anti-angiogenic proteins and methods of use thereof |
| 08/22/2001 | CN1309184A Operation of enzymatic vitality of protoporphyrin primary oxidase in eukaryote |
| 08/21/2001 | US6277980 Mixed backbone oligonucleotide analog having nucleotide sequence complementary to e6/e7 genes; has phosphorothioate bonds and at least one other phosphorus linking group or modification; viricides |
| 08/21/2001 | US6277979 KIAA0551 polynucleotides and polypeptides use |
| 08/21/2001 | US6277978 KVLQT1—a long QT syndrome gene |
| 08/21/2001 | US6277977 cDNA clone HAPOI67 that encodes a human 7-transmembrane receptor |
| 08/21/2001 | US6277972 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 08/21/2001 | US6277965 Amino acid sequence of cysteinyl trna (transfer ribonucleic acid) synthetase from chlamydia; bactericides; bacteriostats; enzyme inhibitors; drug screening; diagnosis; vaccines |
| 08/21/2001 | US6277960 Amino acid sequence of g protein coupled receptor; treatment of eating disorders, asthma, parkinson's disease, cardiovascular and nervous system disorders, huntington's disease, tourett's syndrome, and others; diagnosis |
| 08/21/2001 | US6277634 Hybridized with target rna to be cleaved; medical diagnosis or gene therapy, drugs |
| 08/21/2001 | US6277633 Lentivirus-based gene transfer vectors |
| 08/21/2001 | US6277621 Artificial chromosome constructs containing foreign nucleic acid sequences |
| 08/21/2001 | US6277620 Polypeptide for the prevention of bacterial infection; bactericides; for vaccine development |
| 08/21/2001 | US6277613 TRF1 binding protein, methods of use thereof |
| 08/21/2001 | US6277595 Nucleotide sequences coding fatty acid biosynthsis polypeptide; for the prevention of microorganism infection |
| 08/21/2001 | US6277594 Neurogenesis inducing gene |
| 08/21/2001 | US6277585 Vertebrate unc-5 proteins which function as receptor proteins for netrins, a family of cell guidance proteins; use in diagnosis, therapy and in the biopharmaceutical industry |
| 08/21/2001 | US6277575 Process aimed at evidencing the state of a malignant cell |
| 08/21/2001 | US6277574 Genes associated with diseases of the kidney |
| 08/21/2001 | US6277572 Human NADH dehydrogenase subunits |
| 08/21/2001 | US6277373 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase |
| 08/21/2001 | US6277369 The selected cells can thereafter be used as vehicles for transferring genes encoding a therapeutic protein to a mammal, including humans. |
| 08/21/2001 | CA2174315C Oligonucleotide modulation of multidrug resistance-associated protein |
| 08/16/2001 | WO2001059158A1 Compositions and methods for the early diagnosis of ovarian cancer |
| 08/16/2001 | WO2001059152A2 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 08/16/2001 | WO2001059142A1 Antibody gene therapy with adeno-associated viral vectors |
| 08/16/2001 | WO2001059129A2 Mammalian secreted group iii phospholipase a2 |
| 08/16/2001 | WO2001059120A2 Il-17 like molecules and uses thereof |
| 08/16/2001 | WO2001059115A2 83p5g4: a tissue specific protein highly expressed in prostate cancer |
| 08/16/2001 | WO2001059104A1 Partners of ptb1 domain of fe65, preparation and uses |
| 08/16/2001 | WO2001059103A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | WO2001059102A2 Nucleozymes with endonuclease activity |
| 08/16/2001 | WO2001059094A2 Method of regulating transcription in a cell by altering remodeling of cromatin |
| 08/16/2001 | WO2001059088A2 Vector |
| 08/16/2001 | WO2001059087A2 Compositions for transfecting nucleic acids and their use |
| 08/16/2001 | WO2001059084A1 Protein c derivatives |
| 08/16/2001 | WO2001059072A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/16/2001 | WO2001059071A2 Methods of preparing and using a viral vector library |
| 08/16/2001 | WO2001059064A2 Nucleic acids, proteins, and antibodies |
| 08/16/2001 | WO2001058954A2 Trade molecules and uses related thereto |
| 08/16/2001 | WO2001058946A2 Polynucleotides and polypeptides encoded thereby |
| 08/16/2001 | WO2001058945A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | WO2001058940A2 Adenoviral capsid containing chimeric protein ix |
| 08/16/2001 | WO2001058937A2 Interferon-alpha induced genes |
| 08/16/2001 | WO2001058936A2 Constructs for delivery of therapeutic agents to neuronal cells |
| 08/16/2001 | WO2001058921A2 Methods and compositions for generating angiostatin |
| 08/16/2001 | WO2001058918A2 Oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments |
| 08/16/2001 | WO2001058916A2 Antibodies to ccr5 |
| 08/16/2001 | WO2001058915A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/16/2001 | WO2001058494A2 Gene therapy for treating ocular-related disorders |
| 08/16/2001 | WO2001058483A2 METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES |
| 08/16/2001 | WO2001058479A1 Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| 08/16/2001 | WO2001058477A2 Immunization of an individual against carcinoma and the preliminary stages thereof |
| 08/16/2001 | WO2001058461A1 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof |
| 08/16/2001 | WO2001024773B1 Liposome-entrapped dna oral vaccines |
| 08/16/2001 | WO2001023550A3 Pca3 messenger rna species in benign and malignant prostate tissues |
| 08/16/2001 | WO2001023416A3 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 08/16/2001 | WO2001010413A3 Periodic structures comprising lipids, polyelectrolytes, and structures-inducing soluble oligovalent linkers |
| 08/16/2001 | WO2001009293A3 Mammalian adhesion protease peptides |
| 08/16/2001 | WO2001007628A3 Human synthetases |
| 08/16/2001 | WO2001007595A3 Novel fibroblast growth factor and nucleic acids encoding same |
| 08/16/2001 | WO2001006989A3 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
| 08/16/2001 | WO2001002556A3 Agents for the diagnosis, prognosis and treatment of malignant diseases |
| 08/16/2001 | WO2000058506A3 Susceptibility to psoriasis |
| 08/16/2001 | WO2000049132A3 Uses of transgenic animals containing a type x collagen mutant |
| 08/16/2001 | WO2000044782B1 Ewing's tumour antigen, nucleic acid and antibodies |
| 08/16/2001 | WO2000029589A8 Methioninase gene therapy for tumor treatment |
| 08/16/2001 | US20010014734 Controllers |
| 08/16/2001 | US20010014476 Region which allows its replication comprises an origin of replication derived from a plasmid or a bacteriophage and whose functionality in the host cell requires the presence of at least one specific protein foreign to host cell |
| 08/16/2001 | US20010014464 Nucleic acid encoding follistatin-3 |
| 08/16/2001 | US20010014447 Methods for the detection of encysted parasites |
| 08/16/2001 | US20010014330 Immunization against endogenous molecules |
| 08/16/2001 | US20010014319 Defective recombinant virus containing at least one inserted gene encoding all or part of lecithin-cholesterol acyltransferase (LCAT) or a variant thereof; treating or preventing dyslipoproteinaemia-related diseases |
| 08/16/2001 | EP1144678A3 Susceptibility to psoriasis |
| 08/16/2001 | EP1123976A1 New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 08/16/2001 | EP1123509A2 Methods of diagnosing or prognosing alzheimer's disease |
| 08/16/2001 | EP1123414A1 Antisense modulation of integrin alpha 4 expression |
| 08/16/2001 | EP1123405A1 Materials and methods involving conditional aggregation domains |
| 08/16/2001 | EP1123401A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
| 08/16/2001 | EP1123396A2 Minimal promoters and uses thereof |
| 08/16/2001 | EP1123392A1 Prv-1 gene and the use thereof |
| 08/16/2001 | EP1123387A2 Mn gene and protein |